| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to | |
| | LMNB2, LOC130063066 (A18V) | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | LMNB2, LOC130063066 (R14G) | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | LMNB2, LOC130063065 (S79L) | Single nucleotide variant (missense variant) | Neurodevelopmental disorder | |
| | | Single nucleotide variant (missense variant) | Microcephaly 27, primary, autosomal dominant | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | LMNB2, LOC130063066 (R14fs) | Duplication (frameshift variant) | not provided | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | LMNB2, LOC130063065 (R73P) | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Progressive myoclonic epilepsy type 9 +1 more | |
| | LMNB2, LOC130063065 (R87H) | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Deletion (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | LMNB2, LOC130063066 (R13C) | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | LMNB2, LOC130063066 (R10P) | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | LMNB2, LOC130063066 (P15S) | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | LMNB2, LOC130063066 (R10L) | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Progressive myoclonic epilepsy type 9 +1 more | |
| | LMNB2, LOC130063066 (Q12P) | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | LMNB2, LOC130063066 (A17S) | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | LMNB2, LOC130063065 (H59Q) | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Progressive myoclonic epilepsy type 9 +1 more | |
| | LMNB2, LOC130063066 (A19T) | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +3 more | |
| | | Single nucleotide variant | Acquired partial lipodystrophy | |
| | | Single nucleotide variant (missense variant) | not provided | |